Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books.

Peter Breggin has written the definitive text for professionals and the public alike who really want to know the hazards, inadequacies and illusions of psychopharmacology. This book will be a foundation for those who specialize in medication-free treatment. -Kevin F. McCready, PhD Clinical Director, San Joaquin Psychotherapy Center ""This book proves once again that Peter Breggin truly is the 'conscience of American psychiatry.' Breggin shows that the brain-disabling hypothesis of organic psychiatric treatments is overwhelmingly confirmed by clinical experience and the scientific literature. With astounding numbers of elderly, adults, and children on prescribed psychoactive drugs, Brain-Disabling Treatments in Psychiatry should be required reading for all medical interns, practicing physicians, and mental health professionals."" -David Cohen, PhD Professor of Social Services, University of Montreal

• Preface: A Word About WordsAcknowledgmentsIntroduction: Confirming the Science Behind the First EditionThe Brain-Disabling, Spellbinding Effects of Psychiatric Drugs Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrom) Caused by Neuroleptics Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and PsychosisRecent Developments in Antidepressant Label Changes Antidepressant-Induced Mental, Behavioral and Cerebral AbnormalitiesLithium and Other Drugs for Bipolar Disorder Electroconvulsive Therapy (ECT) for DepressionFrom Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's ChildrenStimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse ReactionsAntianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company AdvocatesDrug Company DeceptionsHow to More Safely Stop Taking Psychiatric DrugsFailed Promises, Last Resorts, and PsychotherapyAppendix: Psychiatric Medications by CategoryBibliographyIndex

Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books.

Peter Breggin has written the definitive text for professionals and the public alike who really want to know the hazards, inadequacies and illusions of psychopharmacology. This book will be a foundation for those who specialize in medication-free treatment. -Kevin F. McCready, PhD Clinical Director, San Joaquin Psychotherapy Center ""This book proves once again that Peter Breggin truly is the 'conscience of American psychiatry.' Breggin shows that the brain-disabling hypothesis of organic psychiatric treatments is overwhelmingly confirmed by clinical experience and the scientific literature. With astounding numbers of elderly, adults, and children on prescribed psychoactive drugs, Brain-Disabling Treatments in Psychiatry should be required reading for all medical interns, practicing physicians, and mental health professionals."" -David Cohen, PhD Professor of Social Services, University of Montreal

• Preface: A Word About WordsAcknowledgmentsIntroduction: Confirming the Science Behind the First EditionThe Brain-Disabling, Spellbinding Effects of Psychiatric Drugs Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrom) Caused by Neuroleptics Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and PsychosisRecent Developments in Antidepressant Label Changes Antidepressant-Induced Mental, Behavioral and Cerebral AbnormalitiesLithium and Other Drugs for Bipolar Disorder Electroconvulsive Therapy (ECT) for DepressionFrom Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's ChildrenStimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse ReactionsAntianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company AdvocatesDrug Company DeceptionsHow to More Safely Stop Taking Psychiatric DrugsFailed Promises, Last Resorts, and PsychotherapyAppendix: Psychiatric Medications by CategoryBibliographyIndex

Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books.

Peter Breggin has written the definitive text for professionals and the public alike who really want to know the hazards, inadequacies and illusions of psychopharmacology. This book will be a foundation for those who specialize in medication-free treatment. -Kevin F. McCready, PhD Clinical Director, San Joaquin Psychotherapy Center ""This book proves once again that Peter Breggin truly is the 'conscience of American psychiatry.' Breggin shows that the brain-disabling hypothesis of organic psychiatric treatments is overwhelmingly confirmed by clinical experience and the scientific literature. With astounding numbers of elderly, adults, and children on prescribed psychoactive drugs, Brain-Disabling Treatments in Psychiatry should be required reading for all medical interns, practicing physicians, and mental health professionals."" -David Cohen, PhD Professor of Social Services, University of Montreal

• Preface: A Word About WordsAcknowledgmentsIntroduction: Confirming the Science Behind the First EditionThe Brain-Disabling, Spellbinding Effects of Psychiatric Drugs Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrom) Caused by Neuroleptics Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and PsychosisRecent Developments in Antidepressant Label Changes Antidepressant-Induced Mental, Behavioral and Cerebral AbnormalitiesLithium and Other Drugs for Bipolar Disorder Electroconvulsive Therapy (ECT) for DepressionFrom Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's ChildrenStimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse ReactionsAntianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company AdvocatesDrug Company DeceptionsHow to More Safely Stop Taking Psychiatric DrugsFailed Promises, Last Resorts, and PsychotherapyAppendix: Psychiatric Medications by CategoryBibliographyIndex